Standard Investments LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.

Quarter-by-quarter ownership
Standard Investments LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2017$10,225,000
-17.2%
713,5500.0%2.16%
+21.8%
Q2 2017$12,344,000
+56.8%
713,5500.0%1.77%
+63.8%
Q1 2017$7,870,000
-24.0%
713,5500.0%1.08%
-43.0%
Q4 2016$10,361,000
-60.3%
713,550
-32.9%
1.90%
-60.2%
Q3 2016$26,098,000
+21.9%
1,063,0570.0%4.76%
+63.6%
Q2 2016$21,410,000
-23.5%
1,063,057
-0.1%
2.91%
+4.2%
Q1 2016$27,974,000
-59.4%
1,063,657
+56.9%
2.79%
-41.9%
Q4 2015$68,919,000
+85.8%
678,000
+226.0%
4.81%
+83.4%
Q3 2015$37,103,000
+14.9%
208,000
+43.1%
2.62%
+43.5%
Q2 2015$32,280,000
+485.2%
145,306
+423.2%
1.83%
+438.9%
Q1 2015$5,516,000
-63.4%
27,770
-73.6%
0.34%
-57.7%
Q4 2014$15,051,000
+465.6%
105,172
+418.5%
0.80%
+464.1%
Q3 2014$2,661,000
-92.9%
20,284
-93.1%
0.14%
-93.9%
Q2 2014$37,239,000
+1100.5%
295,267
+1154.9%
2.33%
+704.5%
Q1 2014$3,102,000
-35.9%
23,529
-42.9%
0.29%
-18.8%
Q4 2013$4,838,00041,2090.36%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2014
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders